Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

• Autori principali: Norma A. Téllez-Navarrete (Autore), Lucero A. Ramon-Luing (Autore), Marcela Muñoz-Torrico (Autore), Mario Preciado-García (Autore), Karen Medina-Quero (Autore), Rogelio Hernandez-Pando (Autore), Leslie Chavez-Galan (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2021-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Tuberculosis (TB) is an infectious disease. During TB, regulatory T cells (Treg) are related to poor prognosis. However, information about conventional and unconventional Treg (cTreg and uTreg, respectively) is limited. The tumour necrosis factor (TNF) and its receptors (TNFR1 an...